PAULA TEIXEIRA: Open Payments
NPI 1720050768 · RAYNHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 13 payments from 10 companies in 2025. Trend: 2023 $569 · 2024 $639 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 1 | $113 |
| Novo Nordisk Inc | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 1 | $31 |
| Lilly USA, LLC | 1 | $27 |
| ABBVIE INC. | 1 | $24 |
| SHIELD THERAPEUTICS INC | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
Products named: INSPIRE, Ozempic, AIRSUPRA, MOUNJARO, QULIPTA, ACCRUFER, CAMZYOS, VOQUEZNA.
Industry payments across MA — which companies pay providers there.
